Clinical Trial Update: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes [NA]

View source ↗

Summary

The Antalya IVF-sponsored trial evaluating a dual trigger strategy for intracytoplasmic sperm injection reproductive outcomes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Snippet

Sponsor: Antalya IVF | Conditions: Pregnancy, Ovarian Hyperstimulation Syndrome | NA | Status: WITHDRAWN